| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | B+ | 74 | Strong earnings recovery (EPS growth +35.24% YoY), hyper-growth flag triggered, forward P/E compression (12.35x), analyst consensus buy bias (81%), recent Fed stress test cleared with $30B buyback authorization | 6-12M |
| SA Quality/Value Composite | A- | 82 | P/E 15.21x (reasonable for growth profile), PEG 0.43 (deep discount), forward P/E 12.35x (compression), dividend yield 2.11% (growing), strong revenue growth +99.24% YoY | 1-3M |
| Zacks Earnings Momentum | A | 88 | EPS growth +35.24% YoY; forward guidance raised post Q2; analyst 2026 EPS consensus $11.41 vs current $9.99; Zacks Rank #1 (Strong Buy) as of Jul 17, 2026 | 1-3M |
| Institutional & Smart Money Flow | B+ | 72 | 28 analyst coverage with 81% buy consensus; Morgan Stanley recent upgrade to $129 PT (was $107); stress test pass signals capital flexibility; $30B buyback & 12% dividend increase announced | 6-12M |
| Growth Sustainability & Moat | B | 68 | Revenue growth +99.24% (elevated, likely reflecting recovery post-simplification); hyper-growth flag active but profitability flag weak; CEO Jane Fraser's 5-year transformation still in progress; moat: global franchise, wealth division expansion | 6-12M |
| Valuation & Safety (Pre-Penalty) | B+ | 75 | Current price $127.13, 52-week range $87.94–$147.96 (38.6% YTD return); forward P/E 12.35x offers re-rating buffer; CET1 13.2% (within range); dividend payout 29% (comfortable) | 6-12M |
| Penalty Overlay | −3 | −3 | Weak profitability flag; ROA forecast 0.91% vs industry 1.34%; balance sheet transformation ongoing; Banamex challenges (Mexico exposure); limited visibility on earnings date | 1-3M |
| CONFIDENCE SCORE | A | 85 | High analyst coverage (28 analysts); recent stress test validation; strong EPS revisions trajectory; institutional consensus buy (81%); data freshness Jul 30, 2026 | 1-3M |
| Volatility & Drawdown Risk | C+ | 60 | Beta 1.11 (moderate equity risk premium); intraday range today -4.03% (margin pressure from broader market); 52-week low $87.94 (40% below current) signals drawdown exposure; sector sensitivity to rates | 1-3M |
| Crowding Risk Flag | MEDIUM | 65 | 81% buy consensus is elevated; recent analyst upgrades (Morgan Stanley, Wells Fargo); $30B buyback may support bid; options flow suggests institutional accumulation but retail crowding low | 3-6M |
Citigroup is positioned within the diversified banking sector as a systemically important global institution with significant investment banking, wealth management, and consumer lending exposure. Its FY2026 revenue growth of +99.24% significantly outpaces the banking industry average, reflecting a recovery from multi-year simplification efforts and elevated capital markets activity. The forward P/E of 12.35x represents meaningful compression versus historical averages and peers like JPMorgan Chase and Goldman Sachs, suggesting valuation reset potential. However, profitability headwinds (ROA forecast 0.91% vs. industry 1.34%) and ongoing transformation costs temper enthusiasm. Relative to diversified bank peers, C trades at a quality discount despite strong earnings momentum, with analyst community positioning it as a "catch-up" recovery story in a resilient financial services sector.
According to 15 Wall Street analysts, the average Citigroup price target is $150.67, with the highest forecast at $176.00 and the lowest at $135.00. This reflects potential upside of 17.05% from the current price of $128.72. Multiple surveys show consistent bullish positioning: 28 analysts have set an average price target of $150.48 USD , while 22 analysts polled by S&P Global have a consensus "Buy" rating with an average price target of $146.93. Recent notable upgrades include Morgan Stanley's price target raised to $129 from $107 with an Overweight rating. Out of 15 analysts, 10 (66.67%) recommend C as a Strong Buy, 3 (20%) as Buy, and 2 (13.33%) as Hold.
EPS Growth YoY: +35.24% | Revenue Growth YoY: +99.24%
| Metric | Value | Assessment |
|---|---|---|
| TTM EPS | $9.99 | Strong earnings delivery |
| EPS Growth YoY | +35.24% | Robust double-digit growth |
| Revenue Growth YoY | +99.24% | Exceptional top-line expansion |
| Forward P/E | 10.88x | Implies forward earnings power |
| Guidance Trend | Data unavailable | Limited forward visibility |
| Metric | Value | Assessment |
|---|---|---|
| Gross Margin | Not disclosed | Banking industry standard; detailed P&L not available |
| Operating Margin | Not disclosed | Coverage constrained |
| Net Margin | Not disclosed | Coverage constrained |
| ROE | Not disclosed | Critical metric absent |
| ROIC | Not disclosed | Critical metric absent |
| Beta | 1.12 | Moderately correlated with market; ~12% higher volatility than S&P 500 |
| Free Cash Flow | Not disclosed | Coverage constrained |
| Metric | Value | Assessment |
|---|---|---|
| Cash & Equivalents | Not disclosed | Coverage constrained |
| Total Debt | Not disclosed | Coverage constrained |
| Net Debt | Not disclosed | Coverage constrained |
| Net Debt / EBITDA | Not disclosed | Coverage constrained |
| Interest Coverage | Not disclosed | Coverage constrained |
| Current Ratio | Not disclosed | Coverage constrained |
| Share Dilution Trend | Not monitored | Data unavailable |
| Metric | Value | Context |
|---|---|---|
| Trailing P/E | 16.27x | Mid-to-premium for banking sector |
| Forward P/E | 10.88x | Attractive relative to TTM; implies strong near-term earnings |
| PEG Ratio | 0.46 | Highly attractive; growth significantly outpaces valuation |
| P/S (implied) | Not disclosed | Revenue data unavailable for direct calculation |
| P/FCF | Not disclosed | FCF data unavailable |
| EV/EBITDA | Not disclosed | EBITDA data unavailable for banking institution |
| Dividend Yield | 1.93% | Modest; $2.96 annual dividend per share |
| Metric | Value | Assessment |
|---|---|---|
| Consensus Rating | Not disclosed | Data unavailable |
| Mean Target Price | Not disclosed | Data unavailable |
| High Target | Not disclosed | Data unavailable |
| Low Target | Not disclosed | Data unavailable |
| Implied Upside | Not calculable | Target data unavailable |
| Estimate Dispersion | Not available | Coverage constrained |
| Risk Factor | Status | Comment |
|---|---|---|
| Institutional Ownership | Not disclosed | Trend unavailable |
| Insider Activity | Not monitored | Data unavailable |
| Short Interest | Not disclosed | Data unavailable |
| Flag: High Valuation | NO | Valuation deemed attractive by model |
| Flag: Hyper Growth | YES | Revenue +99.24% YoY triggers growth flag |
| Flag: Strong Profitability | NO | Margin & ROE data unavailable; cannot confirm |
| Flag: Weak Balance Sheet | NO | Detailed balance sheet metrics unavailable; regulatory oversight suggests adequate capital |
| Systematic Risk (Beta) | 1.12 | Moderate; ~12% higher volatility than market |
| Sector Risk | MODERATE-HIGH | Banking sector exposed to interest rates, credit cycles, regulatory changes |
- Earnings momentum exceptional: EPS +35.24% YoY, revenue +99.24% YoY signal strong operational performance and market resilience.
- Valuation attractive: Forward P/E 10.88x, PEG 0.46, and 52-week +46.57% return create favorable entry point for growth investors.
- Balance sheet constrained: Critical metrics (cash, debt, leverage, interest coverage) unavailable; recommend validating capital adequacy and liquidity via latest 10-Q.
- Sector and rate risks material: Banking cyclicality, interest rate sensitivity, and regulatory environment require ongoing monitoring; beta 1.12 reflects moderate market correlation.
- Institutional-grade conviction: Strong fundamentals support 1-6M upside, but limited balance sheet transparency and sector headwinds warrant cautious positioning; ideal for tactical accumulation with stop-loss discipline.
C Systematic Research
Citigroup Inc. presents a distinctive valuation profile among large-cap U.S. banks, with systematic screening highlighting a price-to-book ratio of 0.98—trading below tangible equity—while maintaining a profitability trajectory reflected in 35.24% year-over-year EPS growth to $9.99 per share. The current price of $132.45 positions the stock within its 52-week range of $87.94–$147.96, following a period of operational restructuring.
The research perspective identifies several fundamental strengths:
- Valuation discount: The P/E ratio of 12.73 and P/S ratio of 1.1 suggest relative undervaluation compared to book value per share of $121.48, creating a mathematical margin between market price and stated equity.
- Revenue acceleration: The 99.24% year-over-year revenue growth indicates substantial business momentum, though this figure warrants context regarding baseline comparisons and segment composition.
- Operating efficiency: Net margin of 17.37% and operating margin of 23.02% demonstrate improved cost discipline across the banking platform.
Screening models flag risk factors including a debt-to-equity ratio of 3.33, typical for money-center banks but reflecting inherent leverage in the business model. Additionally, the ROE of 8.41% and ROA of 0.65% remain below historical banking sector benchmarks, indicating ongoing margin compression challenges. The beta of 1.11 suggests moderate volatility relative to broader market movements.
Relative to peers JPM, BAC, and WFC, the below-book valuation distinguishes Citigroup's market positioning, with the $227.1 billion market capitalization representing the transformation narrative embedded in current institutional ownership patterns.
Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.